ModelEdge

TherapeuticsMD
TXMD
Filing TypeSC TO-T
Filing Date6/5/2022
Updated6/6/22, 11:02 AM

Filing

SC TO-T
Earnings Release

Exhibits

SC TO-TTender Offer Statement by Third Party
EX-99.(A)(1)(A)EX-99.(A)(1)(A)
EX-99.(A)(1)(B)(I)EX-99.(A)(1)(B)(I)
EX-99.(A)(1)(B)(II)EX-99.(A)(1)(B)(II)
EX-99.(A)(1)(C)EX-99.(A)(1)(C)
EX-99.(A)(1)(D)EX-99.(A)(1)(D)
EX-99.(A)(1)(E)EX-99.(A)(1)(E)
EX-99.(A)(5)(B)EX-99.(A)(5)(B)
EX-99.(B)(1)EX-99.(B)(1)
EX-99.(D)(2)EX-99.(D)(2)
EX-99.(D)(3)EX-99.(D)(3)
EX-FILING FEESEX-FILING FEES
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic